
An appeals court rules on the case of a patient who received medication meant for someone with a similar name.

An appeals court rules on the case of a patient who received medication meant for someone with a similar name.

Compared with mothers of normal weight, heart attacks and stroke were more common in underweight women, overweight women, and obese women.

Average caloric intake in the United States has significantly decreased since 2004, but obesity rates have not declined.

This potentially serious condition is only partially understood, and its triad of symptoms often goes unrecognized.

A poll indicates that many American parents do not recognize that their children are overweight or obese.


A recent study found glucocorticosteroids to be associated with nearly a 70% increased risk of myocardial infarction in patients with rheumatoid arthritis.

There is an ongoing quest for information on this rare and fast-paced form of deep vein thrombosis.


This triple therapy can increase the risk of acute renal failure.

This important document outlines the responsibilities of the extemporaneous compounder.

The Generic Pharmaceutical Association suggests that a eport on the global biosimilar market demonstrates the need for action to make biosimilar versions of biologic medicines available.




Eliquis (apixaban) tablets are approved to reduce the risk of stroke and systemic embolism in adults with nonvalvular atrial fibrillation.


Pharmacists are often the first clinicians to see cases of occupational dermatitis, rhinitis, and asthma.

Anxiety and depression may have a negative impact on self-management of asthma.



Case studies involving azithromycin and arrhythmias and the pertussis vaccine during pregnancy.

Coverage of newly released generic medications.



Coverage of the latest pharmacy technology products.

Babies delivered by cesarean section are 5 times as likely to develop allergies when exposed to common allergens as are babies born naturally, according to the results of a study.

Study finds that omalizumab is effective in treating chronic idiopathic urticaria in patients whose symptoms remained after antihistamine therapy.


A Finnish study finds that men's sperm count remained low for nearly 3 months after they stopped spending time in a sauna.